Skip to content
Home/Companies/Biotech/Cellectis
CE

Cellectis

Biotech·France·Exited 2014·Held 12yr

Cellectis is a biotech company, headquartered in France.

Entry
2002
Hold
12yr
Exit
2014
Est. EV
–

Who owns Cellectis?

Cellectis was owned by Odyssée Venture through Odyssee Venture Funds (1999 vintage) from 2002 to 2014, exited via Secondary.

Hand-verified · updated 2026-05-21

Odyssée Venture
Investor
Odyssée Venture
Odyssee Venture Funds · 1999 · VC

Key facts

HQFrance
SectorBiotech
StatusAcquired
Exit Type
Secondary
Buyer
–
MOIC
–
Exit Year
2014

More from Odyssee Venture Funds

Other portfolio companies in the same fund.

Ausy
Exited 2017
IT ServicesFrance
to
DLSoftware
Exited 2017
SoftwareFrance
to
Emme
Exited 2007
TMTFrance
to
EWave
Exited 2000
E-commerceFrance
to
Focus
Exited 2022
GamingFrance
HFCompany
Active
TelecomFrance

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Isavy Biotech
Active
Ring CapitalFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Adcendo
Active
Jeito CapitalDenmark· 2026
Alveus Therapeutics
Active
Jeito CapitalUS· 2026
Data refreshed weekly · Sourced from public filings